Europe Pharmaceutical Ingredients Market Research Report: Ken Research Europe active pharmaceutical ingredients (API) market accounted for USD 45.77 billion in 2020 and will grow by 7.5% annually over 2020-2027 the rising need for medicine and pharmaceutical agents amid the COVID-19 pandemic. Highlighted with 100 tables and 69 figures, this 167-page report “Europe Active Pharmaceutical Ingredients (API) Market 2021-2027 by Synthesis (Synthetic, Biotech, HPAPI),… Read More »
North America Active Pharmaceutical Ingredients Market Research Report: Ken Research North America active pharmaceutical ingredients (API) market is expected to grow by 5.5% annually in the forecast period and reach USD 106.28 billion by 2027 owing to the rising need for medicine and pharmaceutical agents amid the COVID-19 pandemic. Highlighted with 90 tables and 64 figures, this 161-page report “North America Active Pharmaceutical Ingredients (API)… Read More »
Asia Pacific Active Pharmaceutical Ingredients Market Research Report: Ken Research Asia Pacific active pharmaceutical ingredients (API) market will grow by 9.0% annually with a total addressable market cap of USD 636.1 billion over 2021-2027 driven by the rising need for medicine and pharmaceutical agents amid the COVID-19 pandemic. Highlighted with 97 tables and 67 figures, this 166-page report “Asia Pacific Active Pharmaceutical Ingredients (API) Market… Read More »
Rise in Cases of Metabolic Disorder Expected to Drive Global Orphan Drugs Market: Ken Research Orphan drugs are medical products, which are intended for diagnosis, life-threatening disorders and prevention & treatment of serious diseases. These drugs are developed for treatment of that patients, who are suffering from the serious rare disease for which no or at least one treatment is available. This type of disease affects a very small portion… Read More »
Increasing Trends In The Global Orphan Drugs Market Outlook: Ken Research The new-born screening, construction, and legislation of the national strategies are the foremost happening being carried out in the orphan drugs market? Whereas, the orphan or rare diseases rarely occur among the people, which is near about 7 out of 10,00 humans. Moreover, approximately 5,000 to 8,000 infrequent diseases have been acknowledged and the source… Read More »
